CGEM CGEM R2K
$16.44
+90.17% 1Y
Market & Price
Market Cap
-
Current Price
$16.44
High / Low (52W)
$16.44 / $5.75
Beta
-
Valuation
Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-
Profitability & Returns
ROCE
-58.85%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$-0.75
EPS (TTM)
$-
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$448.37M
Current Assets
$386.76M
Working Capital
$349.01M
Ownership
Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-
Financial Snapshot
Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-
Growth (CAGR)
Revenue 5Y
-
Profit 5Y
-99.24%
Revenue (YoY)
-
Earnings (YoY)
-
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Earnings shrank at -99.2% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Ad space
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 18.94M | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 55.00M | 75.80M | 55.59M | 55.26M | 53.70M |
| Operating Income | -5.54M | -14.12M | -11.50M | 1.37M | -16.60M | -18.38M | -32.66M | 239.68M | -29.77M | -62.76M | -37.60M | -45.24M | -42.99M | -50.03M | - | - | -55.00M | -75.80M | -55.59M | -55.26M | -53.70M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -54.92M | -75.72M | -55.52M | -55.18M | -53.62M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -48.50M | -70.06M | -50.61M | -50.71M | -49.66M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -4.97M | -8.62M | -9.86M | -70.00K | -15.64M | -17.35M | -12.10M | 174.90M | -24.80M | -57.96M | -32.21M | -39.18M | -37.15M | -42.03M | - | - | -48.50M | -70.06M | -50.61M | -50.71M | -49.66M |
| Diluted EPS | - | - | - | - | -0.36 | -0.40 | -0.27 | 3.77 | -0.54 | -1.42 | -0.82 | -0.91 | -0.86 | -0.75 | - | - | -0.74 | -1.07 | -0.77 | -0.77 | -0.75 |
| R&D Expense | 4.17M | 12.50M | 9.91M | 12.41M | 11.78M | 12.68M | 24.54M | 26.41M | 19.68M | 52.10M | 27.39M | 33.82M | 30.65M | 36.26M | 35.51M | - | 41.46M | 61.03M | 41.97M | - | 42.12M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | 132.14M | 190.65M | 196.92M | 241.65M |
| Operating Income | -60.34M | - | -132.14M | -190.65M | -196.92M | -241.65M |
| EBITDA | - | - | -132.04M | -190.34M | -196.61M | -241.34M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | - | 151.32M | -169.22M | -167.46M | -219.88M |
| Tax Provision | - | - | 42.12M | -14.12M | 117.00K | 0 |
| Net Income | -51.80M | - | 111.21M | -153.16M | -167.38M | -219.88M |
| Diluted EPS | - | -1.52 | 2.38 | -3.21 | -2.78 | - |
| R&D Expense | 43.21M | 57.75M | 91.95M | 148.16M | 142.90M | 187.40M |
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | - |
Compounded Profit Growth
| 5 Years: | -99.24% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +90.17% |
| 6 Months: | +39.44% |
| 3 Months: | +6.06% |
| 1 Month: | +27.94% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | - | 214.71M | - | 561.12M | 484.18M | 621.82M | 448.37M |
| Current Assets | - | - | - | 474.47M | 480.19M | 414.67M | 386.76M |
| Cash & Equivalents | - | 168.20M | - | 156.15M | 98.43M | 83.00M | 88.33M |
| Inventory | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - |
| Total Liabilities | - | 14.39M | - | 26.09M | 30.29M | 31.50M | 39.64M |
| Current Liabilities | - | 14.32M | - | 22.50M | 28.14M | 30.65M | 37.74M |
| Long Term Debt | - | - | - | - | - | - | - |
| Total Debt | - | - | - | 5.19M | 3.59M | 2.15M | 2.68M |
| Total Equity | 97.00M | 199.01M | - | 535.03M | 453.70M | 590.33M | 408.73M |
| Shares Outstanding | - | - | - | 45.80M | 42.90M | 58.51M | 60.24M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -29.77M | - | -126.66M | -134.28M | -145.30M | -175.75M |
| Investing Cash Flow | -5.42M | - | 248.97M | 35.81M | -136.31M | 179.99M |
| Financing Cash Flow | 140.14M | - | -25.93M | 40.75M | 266.19M | 1.09M |
| Capital Expenditure | -10.00K | - | -1.13M | -208.00K | - | -49.00K |
| Free Cash Flow | -29.78M | - | -127.80M | -134.48M | -145.30M | -175.80M |
| Net Change in Cash | - | - | 96.38M | -57.72M | -15.43M | 5.33M |
| Share Buybacks | 6.57M | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - |
| ROE % | -26.0% | - | 20.8% | -33.8% | -28.4% | -53.8% |
| ROCE % | -30.1% | - | -24.5% | -41.8% | -33.3% | -58.8% |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CGEM
No recent headlines available.